--- title: "12 Health Care Stocks Moving In Wednesday's Intraday Session" description: "In Wednesday's intraday session, several health care stocks experienced significant movements. Larimar Therapeutics (LRMR) surged 58.4% to $5.84, while Cardio Diagnostics (CDIO) rose 26.13% to $4.17. " type: "news" locale: "en" url: "https://longbridge.com/en/news/276919498.md" published_at: "2026-02-25T17:05:39.000Z" --- # 12 Health Care Stocks Moving In Wednesday's Intraday Session > In Wednesday's intraday session, several health care stocks experienced significant movements. Larimar Therapeutics (LRMR) surged 58.4% to $5.84, while Cardio Diagnostics (CDIO) rose 26.13% to $4.17. Acadia Healthcare (ACHC) and NovoCure (NVCR) saw increases of 23.99% and 23.55%, respectively. Conversely, CASI Pharmaceuticals (CASI) plummeted 57.7% to $0.34, with MannKind (MNKD) and 20/20 Biolabs (AIDX) also facing declines of 37.1% and 30.83%. The Q4 earnings reports were released today for several companies. ### Gainers - **Larimar Therapeutics** (NASDAQ:LRMR) shares moved upwards by 58.4% to $5.84 during Wednesday's regular session. The company's market cap stands at $306.6 million. - **Cardio Diagnostics Hldgs** (NASDAQ:CDIO) stock moved upwards by 26.13% to $4.17. The company's market cap stands at $6.0 million. - **Acadia Healthcare Co** (NASDAQ:ACHC) stock rose 23.99% to $21.29. The company's market cap stands at $1.5 billion. The company's, Q4 earnings came out today. - **NovoCure** (NASDAQ:NVCR) stock increased by 23.55% to $14.51. The company's market cap stands at $1.3 billion. - **VolitionRX** (AMEX:VNRX) shares increased by 20.6% to $0.23. The company's market cap stands at $26.2 million. - **C4 Therapeutics** (NASDAQ:CCCC) stock rose 18.84% to $2.84. The company's market cap stands at $222.4 million. ### Losers - **CASI Pharmaceuticals** (NASDAQ:CASI) stock declined by 57.7% to $0.34 during Wednesday's regular session. The market value of their outstanding shares is at $12.3 million. - **MannKind** (NASDAQ:MNKD) shares fell 37.1% to $3.48. The company's market cap stands at $1.6 billion. - **20/20 Biolabs** (NASDAQ:AIDX) shares fell 30.83% to $5.52. The market value of their outstanding shares is at $82.5 million. - **Geron** (NASDAQ:GERN) stock fell 18.72% to $1.58. The market value of their outstanding shares is at $1.2 billion. As per the press release, Q4 earnings came out today. - **Ironwood Pharmaceuticals** (NASDAQ:IRWD) shares fell 18.47% to $3.09. The market value of their outstanding shares is at $616.5 million. As per the news, the Q4 earnings report came out today. - **Gossamer Bio** (NASDAQ:GOSS) stock decreased by 16.86% to $0.35. The company's market cap stands at $96.1 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/ This article was generated by Benzinga's automated content engine and reviewed by an editor. ### Related Stocks - [BIB.US - Proshares Ultra Nasdaq Biotech](https://longbridge.com/en/quote/BIB.US.md) - [CDIOW.US - CARDIO DIAGNOSTICS HOLDINGS INC C/WTS (10/25/2027) TO PUR COM](https://longbridge.com/en/quote/CDIOW.US.md) - [IHE.US - iShares US Pharma](https://longbridge.com/en/quote/IHE.US.md) - [XLV.US - Health Care Select Sector SPDR](https://longbridge.com/en/quote/XLV.US.md) - [XBI.US - SPDR S&P Biotech](https://longbridge.com/en/quote/XBI.US.md) - [AIDX.US - 20/20 Biolabs](https://longbridge.com/en/quote/AIDX.US.md) - [IDNA.US - iShares Genomics Immunology and Healthcare ETF](https://longbridge.com/en/quote/IDNA.US.md) - [CDIO.US - Cardio Diagnostics](https://longbridge.com/en/quote/CDIO.US.md) - [LRMR.US - Larimar Therapeutics](https://longbridge.com/en/quote/LRMR.US.md) - [SBIO.US - ALPS Medical Breakthrough](https://longbridge.com/en/quote/SBIO.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | Acadia Healthcare (NASDAQ:ACHC) Updates Q1 2026 Earnings Guidance | Acadia Healthcare (NASDAQ:ACHC) has updated its Q1 2026 earnings guidance, projecting EPS of 0.250-0.300, significantly | [Link](https://longbridge.com/en/news/276931380.md) | | Acadia Healthcare (NASDAQ:ACHC) Releases FY 2026 Earnings Guidance | Acadia Healthcare (NASDAQ:ACHC) has updated its FY 2026 earnings guidance, projecting EPS between 1.300-1.550, below the | [Link](https://longbridge.com/en/news/276892406.md) | | Alumis Shares Phase 3 Psoriasis Details, Targets 2H NDA Filing at Oppenheimer Healthcare Conference | Alumis (NASDAQ:ALMS) executives presented Phase 3 psoriasis results for envudeucitinib at the Oppenheimer Healthcare Con | [Link](https://longbridge.com/en/news/277123919.md) | | Biodesix (BDSX) was upgraded to a Buy Rating at William Blair | Biodesix (BDSX) has been upgraded to a Buy rating by William Blair analyst Andrew Brackmann, who has a 4-star rating and | [Link](https://longbridge.com/en/news/277130908.md) | | Where Icon Stands With Analysts | In the past three months, analysts have provided varied ratings on Icon (NASDAQ:ICLR), with an average 12-month price ta | [Link](https://longbridge.com/en/news/276635297.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.